Baclofen toxicity: Difference between revisions
(Created page with "==Background== *Indications include MS, muscle spasticity pain *GABAb receptor agonist ==Toxicity== *Adverse effects: **Drowziness, dizziness **N/V **Seizures, delirium, AMS...") |
No edit summary |
||
| Line 19: | Line 19: | ||
==References | ==References== | ||
*Jung, M. “Baclofen Overdoses”. Maryland Poison Center, University of Maryland School of Pharmacy. www.mdpoison.com Accessed April 29th, 2014. | *Jung, M. “Baclofen Overdoses”. Maryland Poison Center, University of Maryland School of Pharmacy. www.mdpoison.com Accessed April 29th, 2014. | ||
*Nicola Y Leung, Ian M Whyte, Geoffrey K Isbister Baclofen overdose: defining the spectrum of toxicity. Emerg Med Australas: 2006, 18(1);77-82 | *Nicola Y Leung, Ian M Whyte, Geoffrey K Isbister Baclofen overdose: defining the spectrum of toxicity. Emerg Med Australas: 2006, 18(1);77-82 | ||
Revision as of 23:54, 16 July 2015
Background
- Indications include MS, muscle spasticity pain
- GABAb receptor agonist
Toxicity
- Adverse effects:
- Drowziness, dizziness
- N/V
- Seizures, delirium, AMS
- Bradycardia, hypotension, respiratory compromise
Management
- Diagnosis of exclusion
- Activated charcoal for recent ingestion
- Supportive care:
- IV fluids, respiratory care
- Benzodiazepines for seizures
- Hemodialysis for very severe toxicity
References
- Jung, M. “Baclofen Overdoses”. Maryland Poison Center, University of Maryland School of Pharmacy. www.mdpoison.com Accessed April 29th, 2014.
- Nicola Y Leung, Ian M Whyte, Geoffrey K Isbister Baclofen overdose: defining the spectrum of toxicity. Emerg Med Australas: 2006, 18(1);77-82